OUR COMPANIES

Able is transforming how companies handle employee onboarding through their sophisticated automation platform. Their comprehensive solution streamlines the traditionally complex and time-consuming process of bringing new employees into organizations, reducing onboarding time by up to 90% while ensuring compliance and accuracy.

The platform features intelligent document management, automated workflow creation, and seamless integration with existing HR systems. Able's technology handles everything from I-9 verification to background checks, making it particularly valuable for high-volume hiring industries like healthcare and staffing agencies.

Their mobile-first approach allows candidates to complete paperwork from any device, while built-in compliance tools automatically update forms based on changing regulations. The platform's analytics dashboard provides real-time insights into onboarding metrics, helping organizations identify bottlenecks and optimize their processes.

Afference bridging the gap between digital and physical tactile experiences via neural haptics. Their flagship product, the Afference Ring, utilizes advanced neural stimulation to create artificial touch sensations without direct skin contact, enhancing interactions across various devices such as VR, AR, mobile phones, and computers. 

Winner of CES 2024 Best of Innovation Award, and leveraging technology out of Case Western Reserve University, the team is enabling "touch" for today's digital world.

Alviere is revolutionizing embedded finance through its comprehensive HIVE platform, enabling businesses to seamlessly integrate financial services into their existing operations. The company's enterprise-grade solution allows organizations to offer banking, payment, and card services without the complexity of building financial infrastructure from scratch.

Their HIVE platform provides a full suite of financial capabilities, including digital wallets, cards, payments, and core banking services. This allows businesses to expand their revenue streams while maintaining full regulatory compliance and security standards. Alviere's white-label solutions enable brands to maintain their identity while offering sophisticated financial products.

The company's technology stack includes advanced fraud prevention, KYC/AML compliance, and real-time transaction monitoring, making it particularly valuable for enterprises looking to enter the financial services space without compromising on security or regulatory requirements.

Aware (AwareHQ) has established itself as a leader in enterprise collaboration security and insights, providing organizations with comprehensive governance and risk management for digital communications. Their platform helps enterprises secure and gain insights from collaboration tools like Microsoft Teams, Slack, and Workplace from Meta.

The company's technology leverages artificial intelligence and machine learning to monitor digital conversations, identify potential risks, and ensure compliance across workplace collaboration platforms. Their solution addresses critical challenges including insider threats, data loss prevention, compliance violations, and behavioral analytics, while maintaining employee privacy and organizational transparency.

Aware's platform stands out for its ability to provide contextual intelligence and human-centric insights, helping organizations manage the complexities of modern digital workplace communication. Their comprehensive approach includes features for content monitoring, information governance, risk management, and behavioral analytics, enabling organizations to maintain security while fostering productive collaboration. The company has gained significant traction with large enterprises looking to secure their digital communications while maintaining compliance with industry regulations.

Clarametyx Biosciences is at the forefront of developing novel antibacterial therapies, focusing on combating antibiotic-resistant infections through their innovative approach to bacterial biofilm disruption. Their proprietary platform technology targets the universal underlying structures of bacterial biofilms, potentially revolutionizing the treatment of resistant infections.

The company's research focuses on developing therapeutic antibodies that can effectively penetrate and disrupt bacterial biofilms, which are typically resistant to conventional antibiotics. This approach could potentially transform the treatment landscape for serious bacterial infections, particularly those involving antibiotic-resistant strains.

Their technology platform has shown promise in addressing infections across multiple bacterial species, offering a potential solution to one of healthcare's most pressing challenges. The company's work represents a significant advance in the fight against antimicrobial resistance, with applications across various medical conditions.

Complion has established itself as a leader in regulatory document management for clinical research, providing a comprehensive platform that streamlines the complex world of clinical trial documentation. Their solution addresses the challenging aspects of managing regulatory documents across multiple research sites and studies.

The platform integrates sophisticated document management capabilities with workflow automation, ensuring compliance with regulatory requirements while significantly reducing administrative burden. Complion's system handles everything from standard operating procedures to regulatory submissions, making it an essential tool for research institutions and clinical trial sites.

Their technology includes advanced features such as electronic signatures, automated version control, and real-time compliance checking, helping research organizations maintain regulatory compliance while accelerating study startup times and reducing operational costs.

ConnXus is a pioneering provider of supplier diversity and procurement solutions, dedicated to enhancing the visibility and inclusion of diverse suppliers within corporate supply chains.

With a comprehensive database of millions of global suppliers, ConnXus enables organizations to identify potential partners that meet both sourcing requirements and diversity criteria.

The acquisition by Coupa has allowed ConnXus to integrate its capabilities into Coupa's Business Spend Management platform, enhancing its mission to promote supplier diversity as a business imperative rather than a compliance obligation.

The platform features tools like myConnXion, which facilitates an open-ended supplier network, and robust supplier master data management capabilities that streamline sourcing efforts.

ConnXus continues to play a vital role in helping companies align their procurement strategies with corporate social responsibility goals while ensuring compliance with federal mandates on supplier diversity.

DOmedia has transformed the out-of-home advertising industry with their comprehensive platform that connects media buyers with sellers in an efficient, automated marketplace. Their technology streamlines the traditionally complex process of planning, purchasing, and managing outdoor advertising campaigns.

The platform incorporates sophisticated planning tools, automated proposal generation, and detailed analytics capabilities, making it easier for advertisers to find and book the right outdoor advertising spaces. DOmedia's solution includes features for campaign management, inventory tracking, and performance measurement.

Their marketplace has become a central hub for the out-of-home advertising industry, processing millions of dollars in advertising transactions and helping both buyers and sellers operate more efficiently in an increasingly digital landscape.

Docket is enhancing productivity for mid-market manufacturers by connecting people, data, and processes on the shop floor via their frontline operations platform. The platform offers personalized dashboards, digital work instructions, an intuitive user interface, reporting and analytics, and multilingual support to streamline operations and improve efficiency, all while integrating seamlessly with various ERPs, QMS, and IoT platforms. 

The solution addresses process optimization, workforce connectivity, and business intelligence, providing tailored solutions to overcome operational hurdles and drive continuous improvement.

eFuse is the #1 global gaming platform that serves gamers, publishers, and brands. They host large gaming events and tournaments and provide end-to-end services for publishers and brands to connect with the gaming community. eFuse offers advertising solutions like digital display ads, picture-in-picture livestream ads, and custom-branded content with creators.

Enable Injections is pioneering the future of drug delivery with their innovative enFuse® platform, a wearable technology designed to revolutionize how patients receive high-volume and viscous medications. Based in Cincinnati, Ohio, the company addresses the growing need for at-home administration of complex biological drugs.

Their flagship enFuse device allows patients to self-administer medications subcutaneously with minimal discomfort, accommodating volumes from 5mL to 50mL. The technology features smart monitoring capabilities, automatic needle retraction for safety, and Bluetooth connectivity for tracking adherence and providing real-time feedback.

Enable Injections partners with pharmaceutical companies to optimize their biologics for delivery through the enFuse platform, potentially expanding treatment options for conditions requiring regular high-volume drug administration. Their focus on user-friendly design and patient comfort has made them a leader in the evolving landscape of drug delivery systems.

Eridu.AI is developing cutting-edge hardware solutions designed to enhance the training performance of large AI models. Founded in 2023, the company addresses the challenges in AI infrastructure by creating advanced silicon and optical hardware that optimizes GPU utilization, accelerates training cycles, and reduces both power consumption and costs. 

Their innovative approach aims to streamline the process of AI model development, making it more efficient and scalable. Their team combines expertise in semiconductors, systems, and software to revolutionize AI hardware acceleration. 

FenixPyre provides cutting-edge data security solutions that protect sensitive information through advanced encryption and access control mechanisms. Their technology ensures that data remains secure even when it moves beyond traditional network boundaries, addressing one of the most critical challenges in modern data security.

The company's platform offers dynamic data protection that follows files wherever they go, maintaining security through sophisticated encryption that remains active even when files are shared or copied. Their solution includes features like real-time access control, detailed activity monitoring, and the ability to remotely revoke access to sensitive data.

FenixPyre's technology is particularly valuable for organizations handling sensitive information in regulated industries, providing granular control over data access while maintaining seamless user experience and workflow efficiency.

Genetesis is revolutionizing cardiac diagnostics with their innovative CardioFlux platform, which utilizes magnetocardiography (MCG) technology to provide precise, non-invasive cardiac imaging. Based in Mason, Ohio, the company has developed a solution that addresses the limitations of traditional cardiac diagnostic tools, particularly in emergency department settings.

Their CardioFlux system captures the heart's magnetic fields without radiation exposure or direct patient contact, providing physicians with detailed functional cardiac information in minutes. This technology is particularly valuable for rapidly assessing patients presenting with chest pain, potentially reducing unnecessary hospital admissions and improving triage accuracy.

The platform combines advanced sensor technology with sophisticated algorithms to create detailed 3D visualizations of cardiac electrical activity. This approach offers significant advantages over traditional ECG testing, providing more comprehensive data while maintaining patient comfort and safety.

Immuta provides a sophisticated data access control and security platform that helps organizations automate data governance, security, and privacy compliance. Their solution enables companies to safely share sensitive data while maintaining regulatory compliance across multiple jurisdictions and frameworks.

The platform features automated policy enforcement, dynamic data masking, and detailed audit capabilities, making it easier for organizations to manage complex data access requirements. Immuta's technology integrates with existing data platforms and analytics tools, providing seamless security without disrupting workflows.

Their solution is particularly valuable for organizations dealing with sensitive data in regulated industries, offering features like automated privacy protection, real-time access control, and comprehensive audit trails for compliance reporting.

Invirsa is advancing ocular therapy through their proprietary Invisasome technology, developing innovative solutions for targeted medication delivery to the eye. Their technology platform addresses the challenges of traditional eye drop medications, potentially improving treatment outcomes for various ocular conditions.

The company's Invisasome technology enhances drug delivery efficiency, potentially reducing the frequency of applications while improving therapeutic outcomes. Their approach focuses on optimizing how medications interact with ocular tissues, potentially leading to better absorption and more effective treatment.

Invirsa's development pipeline includes treatments for various eye conditions, with their technology platform showing promise in improving the delivery of both existing and new therapeutic compounds to the eye.

Lentechs is improving vision through innovative contact lens technology, providing glasses-like vision quality at all distances for individuals with presbyopia via their soft, suspended contact lenses. 

Unlike traditional contact lenses that adhere to the eye's surface, Lentechs' lenses are uniquely suspended behind the upper eyelid. This patented design allows the eye to move freely beneath the lens, enabling access to the specific prescription needed for each visual distance correction. 

Niobium is focused on developing advanced microtechnology solutions that cater to various industries, including healthcare and electronics. 

Their innovative approach combines engineering expertise with cutting-edge materials science to create products that enhance performance and efficiency. Niobium's commitment to research and development drives their ability to deliver high-quality solutions that meet the evolving needs of their clients.

As they enter into partnership with other industry leaders, Niobium aims to broaden its market presence and continue pushing the boundaries of microtechnology applications.

S4 Medical has developed innovative technology focused on protecting the esophagus during cardiac ablation procedures, addressing a critical safety concern in the treatment of atrial fibrillation. Their solution aims to reduce complications and improve outcomes in cardiac procedures.

The company's technology provides real-time protection of the esophagus, potentially reducing the risk of thermal injury during ablation procedures. This advancement could significantly improve the safety profile of cardiac ablation while maintaining procedure efficiency.

Their approach represents a significant step forward in cardiac procedure safety, potentially reducing complications and improving outcomes for patients undergoing treatment for cardiac arrhythmias.

ScriptDrop has developed a comprehensive prescription delivery solution that connects pharmacies, patients, and couriers in a seamless ecosystem. Their platform addresses the critical challenge of medication access and adherence, potentially improving healthcare outcomes through reliable prescription delivery.

The company's technology integrates with existing pharmacy management systems, providing automated delivery scheduling, real-time tracking, and detailed reporting capabilities. Their solution includes features for both on-demand and scheduled deliveries, making it flexible enough to meet various patient needs.

ScriptDrop's platform has become particularly valuable in improving medication adherence and reducing prescription abandonment, especially for patients with limited mobility or transportation options.

Spirosure is at the forefront of respiratory diagnostics, specializing in the development of technologies that measure Fractional Exhaled Nitric Oxide (FeNO), a critical biomarker for allergic inflammation in asthmatic patients.

Their flagship product, the Fenom Pro®, provides clinicians with a reliable tool for diagnosing and managing asthma by accurately measuring FeNO levels. This technology is particularly significant given the rising prevalence of asthma globally, affecting over 300 million individuals.

The acquisition by CAIRE Inc. has enabled Spirosure to expand its reach and integrate its innovative solutions into a broader portfolio of respiratory care products, enhancing patient management strategies in clinical settings.

Stirling Ultracold, based in Athens, Ohio, develops and manufactures ultra-low temperature (ULT) freezers for fields like life sciences, biopharma, and clinical trials. Their freezers, operating from -20°C to -86°C, use energy-efficient Stirling engine technology, reducing energy use by up to 75% compared to traditional models.

Known for reliability and precise temperature control, their freezers ensure sample safety in demanding environments. They also offer portable ULT models like the ULT25NEU for field research. Stirling's use of 100% natural refrigerants eliminates harmful HFCs, supporting global sustainability efforts.

The company's innovative approach to cold storage has made them a leader in the life sciences industry, particularly in applications requiring precise temperature control and reliable sample preservation.

Trace is an innovative company that specializes in creating immersive 3D experiences using augmented reality (AR) and virtual reality (VR) technologies.

Their platform allows users to visualize complex data and environments in an interactive manner, enhancing understanding and engagement. By leveraging cutting-edge technology, Trace aims to transform industries such as education, healthcare, and real estate through enhanced visualization tools that facilitate better decision-making and learning experiences.